With the legalization of recreational marijuana looming in Canada, therapeutic producer Aurora said Monday it was acquiring rival MedReleaf Corp. in a huge deal set to create a giant company.
May 14, 2018
0
3
Canadian cannabis grower and seller Aurora Cannabis announced Wednesday a friendly acquisition of CanniMed Therapeutics in a deal valued at an estimated Can$1.1 billion (US$890 million) to create a global pot behemoth.
Jan 24, 2018
0
1
Peter Stock, MD, PhD, a transplant surgeon at UC San Francisco, considers himself a representative specimen of his profession. "I think we're all typically atypical," he said, by which he means that transplant surgeons thrive ...
Jun 21, 2017
0
10
Each year, there are approximately 10 million cases of venous thromboembolism (VTE) worldwide. VTE, the formation of blood clots in the vein, is a dangerous and potentially deadly medical condition and is a leading cause ...
Jan 7, 2016
0
15
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
Horizon Pharma is pushing ahead with its hostile, $2.4-billion bid to buy Depomed by starting an offer to exchange a portion of its stock for shares of the rival drugmaker.
Sep 8, 2015
0
4
Dublin-based pharmaceutical group Shire said Tuesday it had bid $30 billion (27 billion euros) for Baxalta to form a global biotech company, an offer soundly rejected by the US firm.
Aug 4, 2015
0
6
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
Jul 27, 2015
0
9
Drugmaker Horizon Pharma PLC is boosting its offer for fellow drugmaker Depomed to $33 per share.
Jul 21, 2015
0
4
